Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
Author(s) -
Katherine L. Williams,
Wahala M. P. B. Wahala,
Susana Orozco,
Aravinda M. de Silva,
Eva Harris
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jyt6-yd89
Subject(s) - dengue virus , virology , antibody dependent enhancement , dengue vaccine , dengue fever , in vivo , serotype , antibody , envelope (radar) , virus , medicine , biology , immunology , computer science , microbiology and biotechnology , telecommunications , radar
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom